32.57 USD
↘ 1.18 (3.50%)AT CLOSE (11:59 AM EDT)
Quince Therapeutics, Inc. Common Stock
QNCXNASDAQ • USD
32.54
↘ 0.04 (0.11%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
32.54
↘ 0.04 (0.11%)
Market: CLOSED
Quince Therapeutics, Inc. Common Stock (QNCX) trades at $33.08 per share. Our models show a "Neutral" technical signal alongside a "Sell" fundamental rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Aug 31, 2026.
Open?$34.04
High?$34.04
Low?$31.47
Prev. Close?$33.75
Volume?33.8K
Avg. Volume?30.5K
VWAP?$32.78
Rel. Volume?1.11x
Bid / Ask
Bid?$17.05 × 100
Ask?$35.00 × 100
Spread?$17.95
Midpoint?$26.03
Valuation & Ratios
Market Cap?33.1M
Shares Out?1.0M
Float?15.3M
Float %?93.7%
P/E Ratio?N/A
P/B Ratio?0.31
EPS?-$93.99
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
Employees
38
Market Cap
34.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2019-05-09
Address
611 GATEWAY BLVD., SUITE 273
SOUTH SAN FRANCISCO, CA 94080
Phone: 415-910-5717
SOUTH SAN FRANCISCO, CA 94080
Phone: 415-910-5717
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?79
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.67Distress
Confidence?43%Low
Short InterestLow
Short % of Float?0.39%Low
Short Interest?60.3K
Days to Cover?1.7
Free Float15.3M
Avg Daily Volume34.9K
Settlement Date2026-08-14
Financial Health
Current Ratio?14.52Strong
Quick Ratio?14.52Strong
Cash Ratio?13.64Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.31CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.7CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-88.1%WEAK▾
S&P3
ROA?-77.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-47001000
Enterprise Value?$-82855258
Fundamentals ratios updated end of day